Abdellah AT, El-Nagary M. Prevalence of P-wave dispersion and interatrial block in patients with systolic heart failure and their relationship with functional status, hospitalization and one-year mortality. Egypt Heart J. 2018;70:181–187.
Soliman EZ, Cammarata M, Li Y. Explaining the inconsistent associations of PR interval with mortality: the role of P-duration contribution to the length of PR interval. Heart Rhythm. 2014;11(1):93–98.
Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA. 2009;301(24):2571–2577.
Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A, et al. Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis. Heart. 2016;102(9):672–680.
Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ. P-wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol. 2009;2(1):72–79.
Magnani JW, Zhu L, Lopez F, Pencina MJ, Agarwal SK, Soliman EZ, et al. P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study and Atherosclerosis Risk in Communities study. Am Heart J. 2015;169(1):53–61.e1.
Chen LY, Soliman EZ. P-wave parameters and indices: a critical appraisal. Circ Arrhythm Electrophysiol. 2022;15(6):e010435.
Bayés de Luna A, Platonov P, Cosio FG, Cygankiewicz I, Pastore C, Baranowski R, et al. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report. J Electrocardiol. 2012;45(5):445–451.
Baranchuk A, Enriquez A, García-Niebla J, Bayés-Genís A, Bayés de Luna A. Bayés’ syndrome: time to consider early anticoagulation? Circulation. 2018;137:?? (review article; Circulation).
Conde D, Seoane L, Gysel M, Mitrione S, Bayés de Luna A, Baranchuk A. Bayés’ syndrome: the association between interatrial block and supraventricular arrhythmias. Expert Rev Cardiovasc Ther. 2015;13(5):541–550.
Seoane L, Conde D, Baranchuk A. Update on Bayés’ syndrome: the association between interatrial block and supraventricular arrhythmias. Expert Rev Cardiovasc Ther. 2019;17(3):225–235.
Martínez-Sellés M, Baranchuk A, Elosua R, Bayés de Luna A. Rationale and design of the BAYES (Interatrial Block and Yearly Events) registry. Clin Cardiol. 2017;40(4):196–199.
O’Neal WT, Zhang Z-M, Loehr LR, Chen LY, Alonso A, Soliman EZ. Electrocardiographic advanced interatrial block and atrial fibrillation risk in the general population. Am J Cardiol. 2016;117(11):1755–1759.
Dilaveris PE, Gialafos JE. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol. 2001;6:159–165.
Gialafos JE, Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Triposkiadis F, et al. P-wave dispersion: a valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol. 1999;4:39–45.
Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, et al. P-wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000;23(7):1109–1112.
Okutucu S, Aytemir K, Oto A. P-wave dispersion: what we know till now? JRSM Cardiovasc Dis. 2016;5:2048004016639443.
Pérez-Riera AR, Barbosa-Barros R, de Abreu LC, Nikus KC, Baranchuk A. P-wave dispersion: an update. Indian Pacing Electrophysiol J. 2016;16(4):126–133.
Senen K, Turhan H, Erbay AR, Basar N, Saatci Yasar A, Sahin O, et al. P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail. 2004;6(5):567–569.
Chandy J, Nakai T, Lee RJ, Bellows WH, Dzankic S, Leung JM. Increases in P-wave dispersion predict postoperative atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg. 2004;98(2):303–310.
Tsioufis C, Syrseloudis D, Hatziyianni A, Tzamou V, Andrikou I, Tolis P, et al. Relationships of C-reactive protein and P-wave dispersion with atrial fibrillation in hypertensive subjects. Am J Hypertens. 2010;23(2):202–207.
Dagli N, Karaca I, Yavuzkir M, Balin M, Arslan N. Are maximum P-wave duration and P-wave dispersion a marker of target organ damage in the hypertensive population? Clin Res Cardiol. 2008;97(2):98–104.
Yazici M, Ozdemir K, Altunkeser BB, Kayrak M, Duzenli MA, Vatankulu MA, et al. The effect of diabetes mellitus on the P-wave dispersion. Circ J. 2007;71(6):880–883.
Demir K, Avci A, Kaya Z, Marakoglu K, Ceylan E, Yilmaz A, et al. Assessment of atrial electromechanical delay and P-wave dispersion in patients with type 2 diabetes mellitus. J Cardiol. 2016;67(4):378–383.
Dogan U, Dogan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, et al. P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci. 2011;9(1):108–114.
Su H-M, Tsai W-C, Lin T-H, Hsu P-C, Lee W-H, Lin M-Y, et al. P-wave dispersion and maximum P-wave duration are independently associated with rapid renal function decline. PLoS One. 2012;7(8):e42815.
Huang JC, Chen SC, Su HM, et al. P-wave dispersion and maximum P-wave duration are associated with renal outcomes in chronic kidney disease. PLoS One. 2014;9:e101962.
Comín-Colet J, Anguita M, Formiga F, Almenar L, Crespo-Leiro MG, Manzano L, et al. Health-related quality of life of patients with chronic systolic heart failure in Spain: results of the VIDA-IC study. Rev Esp Cardiol (Engl Ed). 2016;69(3):256–271.
Sepehrvand N, Savu A, Spertus JA, Dyck JRB, Anderson T, Howlett J, et al. Change of health-related quality of life over time and its association with patient outcomes in patients with heart failure. J Am Heart Assoc. 2020;9(17):e017278.
Inofomoh FO, Familoni OB, Amadi CE. Relationship between P-wave dispersion, left ventricular mass index and function in Nigerian hypertensive patients. Cardiovasc J Afr. 2021;32(6):328–333.
Masood S, Ashraf SMK, Malik MA, Wahab S. P-wave indices and left atrial mechanics as predictors of atrial cardiopathy in embolic stroke of undetermined source. Sci Rep. 2023;13:19965.
Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol. 2005;38(1):43–46.
Gonna H, Gallagher MM, Guo XH, et al. P-wave abnormality predicts recurrence of atrial fibrillation after electrical cardioversion. Ann Noninvasive Electrocardiol. 2014;19(1):57–65.
Can I, Aytemir K, Demir AU, et al. P-wave duration and dispersion in patients with obstructive sleep apnea syndrome: a marker of atrial remodeling? Int J Cardiol. 2009;??:??–??.
Gaisl T, Schlatzer C, Schwarz EI, et al. Simulated obstructive sleep apnea increases P-wave duration and P-wave dispersion. PLoS One. 2016;11(3):e0152994.
Kelmanson IA, et al. Increased P-wave dispersion in patients with obstructive sleep apnea syndrome: a meta-analysis. (Journal/Year as indexed in PubMed). 2022/2023.
Cimci M, et al. Assessment of atrial electromechanical delay and P-wave dispersion in patients with chronic obstructive pulmonary disease. (Turk Kardiyol Dern Ars / or indexed journal). 2020.
Celik Y, et al. Atrial electromechanical delay and P-wave dispersion in chronic obstructive pulmonary disease. (Indexed journal; PMC article). 2021.
Tukek T, et al. Factors associated with the development of atrial fibrillation in COPD: role of P-wave dispersion. (Indexed study; EuropePMC). 2002.
Zagoridis K, et al. P-wave duration and interatrial block as predictors of new-onset atrial fibrillation: a meta-analysis. (Indexed journal). 2023.
Rasmussen MU, et al. P-wave indices as predictors of atrial fibrillation. Ann Noninvasive Electrocardiol. 2020;25:e12751.
Magnani JW, Johnson VM, Sullivan LM, et al. P-wave duration and risk of longitudinal atrial fibrillation in persons ≥60 years old (Framingham Heart Study). Am J Cardiol. 2011;107(6):917–921.e1.
Magnani JW, et al. P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol. 2010;15(4):344–352.
Huang Z, Zheng Z, Wu B, et al. Predictive value of P-wave terminal force in lead V1 for atrial fibrillation occurrence: a meta-analysis. Ann Noninvasive Electrocardiol. 2020;25:e12756.
Soliman EZ, et al. Electrocardiographic P-terminal force in V1 and risk of incident atrial fibrillation / cardiovascular outcomes (ARIC-related). J Am Heart Assoc. 2014;3:e001387.
Wolder LD, et al. Electrocardiographic P terminal force in lead V1, its components, and incident atrial fibrillation and stroke. Heart Rhythm. 2023;20:??–??.
Dogan A, et al. A comparison of P-wave duration and dispersion in early vs late AF after CABG (post-operative AF context). J Electrocardiol. 2003.
Han YC, et al. Association of P-wave dispersion with paroxysmal atrial fibrillation after anterior wall ST-elevation myocardial infarction. Korean Circ J. 2009;39(2):66–71.
Deveci B, Aksakal E, Sahin M. Independent association of P-wave dispersion and P-wave duration parameters with CHA₂DS₂-VASc value. Turk J Clin Lab. 2020;13(4):439–443.
Demarchi AV, et al. CHA₂DS₂-VASc score, P-wave indexes, and echocardiographic parameters in sinus rhythm patients without valvular heart disease. Rev Assoc Med Bras. 2023;69(9):e20230607.